Oral (po) dosing with RSU 1069 or RB 6145 maintains their potency as hypoxic cell radiosensitizers and cytotoxins but reduces systemic toxicity compared with parenteral (ip) administration in mice.

Source:http://linkedlifedata.com/resource/pubmed/id/2061115

Download in:

View as

General Info

PMID
2061115